(Q37500500)

20 August 2017

1 reference

title

Safety of selective serotonin reuptake inhibitors in pregnancy (English)

1 reference

20 August 2017

0 references

Jan M Friedman

2

0 references

author name string

Sura Alwan

series ordinal

1

1 reference

20 August 2017

1 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

23

1 reference

20 August 2017

493-509

1 reference

20 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200923060-00004

20 August 2017

0 references

cites work

The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200923060-00004

Risks associated with selective serotonin reuptake inhibitors in pregnancy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200923060-00004

Perinatal outcome following third trimester exposure to paroxetine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200923060-00004

Neonate characteristics after maternal use of antidepressants in late pregnancy

21 January 2018

1 reference

12 December 2020

Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.

1 reference

12 December 2020

Antidepressant drug selection: criteria and options.

1 reference

12 December 2020

Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

1 reference

12 December 2020

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

1 reference

12 December 2020

Birth outcomes following prenatal exposure to antidepressants.

1 reference

12 December 2020

Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy

1 reference

12 December 2020

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study

1 reference

12 December 2020

Antidepressant drugs during pregnancy and infant congenital heart defect

1 reference

12 December 2020

Maternal life event stress and congenital anomalies

1 reference

12 December 2020

Mouse 5-HT2B receptor-mediated serotonin trophic functions.

1 reference

12 December 2020

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants

1 reference

12 December 2020

Serotonin and morphogenesis. Transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse

1 reference

12 December 2020

Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review

1 reference

12 December 2020

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

12 December 2020

Serotonin and cardiac morphogenesis in the mouse embryo

1 reference

12 December 2020

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors

1 reference

12 December 2020

Teratogenicity of SSRIs--serious concern or much ado about little?

1 reference

12 December 2020

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

1 reference

12 December 2020

The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects

1 reference

12 December 2020

Effect of prenatal diazepam, phenobarbital, haloperidol and fluoxetine exposure on foot shock induced aggression in rats.

1 reference

12 December 2020

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

1 reference

12 December 2020

Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings

1 reference

12 December 2020

Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes

1 reference

12 December 2020

Antidepressant discontinuation syndromes

1 reference

12 December 2020

Serotonin regulates mouse cranial neural crest migration

1 reference

12 December 2020

Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil)

1 reference

12 December 2020

Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.

1 reference

12 December 2020

Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis

1 reference

12 December 2020

Serious life events and congenital malformations: a national study with complete follow-up

1 reference

12 December 2020

Neurodevelopment of children exposed in utero to antidepressant drugs

1 reference

12 December 2020

Psychosocial stress and pregnancy outcome

1 reference

12 December 2020

CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure

1 reference

12 December 2020

Serotonin reuptake inhibitor withdrawal

1 reference

12 December 2020

Paroxetine in the first trimester and the prevalence of congenital malformations

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and adverse pregnancy outcomes

1 reference

12 December 2020

Depression during pregnancy

1 reference

12 December 2020

Serotonin and its transporter on proliferation of fetal heart cells

1 reference

12 December 2020

Birth outcomes following prenatal exposure to fluoxetine

1 reference

12 December 2020

Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials

1 reference

12 December 2020

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.

1 reference

12 December 2020

Preclinical toxicological evaluation of sertraline hydrochloride

1 reference

12 December 2020

Maternal distress and congenital malformations: do mothers of malformed fetuses have more problems?

1 reference

12 December 2020

The reproductive toxicology of paroxetine

1 reference

12 December 2020

Delivery outcome after the use of antidepressants in early pregnancy

1 reference

12 December 2020

Pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects

1 reference

12 December 2020

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

1 reference

12 December 2020

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study

1 reference

12 December 2020

Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics.

1 reference

12 December 2020

Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis.

1 reference

12 December 2020

The medical management of depression

1 reference

12 December 2020

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage

1 reference

12 December 2020

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

1 reference

12 December 2020

Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy

1 reference

12 December 2020

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

1 reference

12 December 2020

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

1 reference

12 December 2020

Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications

1 reference

12 December 2020

Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

1 reference

12 December 2020

Fluoxetine use in early pregnancy

1 reference

12 December 2020

Birth outcomes in pregnant women taking fluoxetine

1 reference

12 December 2020

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

1 reference

12 December 2020

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

1 reference

12 December 2020

Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.

1 reference

12 December 2020

Pharmacologic treatment of depression during pregnancy

1 reference

12 December 2020

Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications

1 reference

12 December 2020

Outcomes of prenatal antidepressant exposure

1 reference

12 December 2020

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn

1 reference

12 December 2020

Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth

1 reference

12 December 2020

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

1 reference

12 December 2020

Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy

1 reference

12 December 2020

Neurotransmitters and neuromodulators during early human development.

1 reference

12 December 2020

Placental passage of antidepressant medications

1 reference

12 December 2020

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data

1 reference

12 December 2020

Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions

1 reference

12 December 2020

Fluoxetine during pregnancy: impact on fetal development

1 reference

12 December 2020

Developmental toxicology studies of fluoxetine hydrochloride administered orally to rats and rabbits

1 reference

12 December 2020

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data

1 reference

12 December 2020

Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo.

1 reference

12 December 2020

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

1 reference

12 December 2020

Citalopram in pregnancy and lactation

1 reference

12 December 2020

Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation

1 reference

12 December 2020

Antepartum and postpartum depression: healthy mom, healthy baby.

1 reference

12 December 2020

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior

1 reference

12 December 2020

A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats

1 reference

12 December 2020

Assessment and treatment of depression during pregnancy: an update

1 reference

12 December 2020

Duration of antidepressant use during pregnancy and risk of major congenital malformations

1 reference

12 December 2020

10.2165/00023210-200923060-00004

Identifiers

DOI

1 reference

PubMed ID

19480468

Dimensions Publication ID

20 August 2017

0 references

1 reference

PubMed ID

19480468